TR199800152T1 - Endotelin Reseptör Antagonistleri - Google Patents

Endotelin Reseptör Antagonistleri

Info

Publication number
TR199800152T1
TR199800152T1 TR1998/00152T TR9800152T TR199800152T1 TR 199800152 T1 TR199800152 T1 TR 199800152T1 TR 1998/00152 T TR1998/00152 T TR 1998/00152T TR 9800152 T TR9800152 T TR 9800152T TR 199800152 T1 TR199800152 T1 TR 199800152T1
Authority
TR
Turkey
Prior art keywords
receptor antagonists
endothelin receptor
triasoles
piroceles
compounds
Prior art date
Application number
TR1998/00152T
Other languages
English (en)
Inventor
Ignacio Luengo Juan
Duncon Wlliott John
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR199800152T1 publication Critical patent/TR199800152T1/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Yeni pirroles, piroseles ve triasolesler bu bilesimleri içeren farmasötik terkipler ve bunlarin tanimlandigi gibi, endotelin reseptörü antagonistleri olarak kullanimlari.
TR1998/00152T 1995-08-02 1996-08-02 Endotelin Reseptör Antagonistleri TR199800152T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01

Publications (1)

Publication Number Publication Date
TR199800152T1 true TR199800152T1 (tr) 1998-05-21

Family

ID=26669471

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00152T TR199800152T1 (tr) 1995-08-02 1996-08-02 Endotelin Reseptör Antagonistleri

Country Status (25)

Country Link
US (5) US5969151A (tr)
EP (2) EP0843551B1 (tr)
JP (2) JPH11511133A (tr)
KR (1) KR19990036032A (tr)
CN (1) CN1196680A (tr)
AP (1) AP9801182A0 (tr)
AT (1) ATE341324T1 (tr)
AU (2) AU6646396A (tr)
BG (1) BG102229A (tr)
BR (1) BR9609914A (tr)
CA (2) CA2228293A1 (tr)
CZ (1) CZ30498A3 (tr)
DE (2) DE69636597T2 (tr)
EA (1) EA000952B1 (tr)
ES (2) ES2273350T3 (tr)
HU (1) HU220776B1 (tr)
MX (1) MX9800975A (tr)
NO (1) NO980422L (tr)
NZ (1) NZ315846A (tr)
OA (1) OA10755A (tr)
PL (1) PL184272B1 (tr)
RO (1) RO115802B1 (tr)
SK (1) SK282584B6 (tr)
TR (1) TR199800152T1 (tr)
WO (2) WO1997004773A1 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5021171A1 (es) * 1997-12-08 2001-03-27 Smithkline Beechman Corp Sal de monoargininilo del acido(e)-3-(1-n-butil-5-(2-(2- carboxifenil)metoxi-4-clorofenil)-1h-pirazol-4-il)-2- ((5-metoxi-2,3-dihidrobenzofuran-5-il)metil)-prop-2-enoico
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
WO2017091513A1 (en) 2015-11-24 2017-06-01 Daiichi Sankyo Company, Limited Novel azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
PT714897E (pt) * 1993-08-18 2001-05-31 Banyu Pharma Co Ltd Derivado ciclopenteno heteroaromatico fundido possuindo actividade de antagonista de endotelinas
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
AU3416995A (en) * 1994-09-02 1996-03-27 Smithkline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
US6353116B1 (en) 2002-03-05
NO980422D0 (no) 1998-01-30
HU220776B1 (hu) 2002-05-28
US6096897A (en) 2000-08-01
NO980422L (no) 1998-03-24
PL324745A1 (en) 1998-06-08
EP0843551B1 (en) 2002-02-06
WO1997004772A1 (en) 1997-02-13
KR19990036032A (ko) 1999-05-25
SK282584B6 (sk) 2002-10-08
US5958968A (en) 1999-09-28
DE69636597T2 (de) 2007-08-16
EP0843551A4 (en) 1998-08-12
CA2228293A1 (en) 1997-02-13
SK11398A3 (en) 1998-07-08
WO1997004773A1 (en) 1997-02-13
ES2171697T3 (es) 2002-09-16
NZ315846A (en) 1999-01-28
JP2001517195A (ja) 2001-10-02
ATE341324T1 (de) 2006-10-15
CZ30498A3 (cs) 1998-07-15
EP0841925B1 (en) 2006-10-04
EA199800185A1 (ru) 1998-10-29
PL184272B1 (pl) 2002-09-30
RO115802B1 (ro) 2000-06-30
OA10755A (en) 2002-12-13
AU6646396A (en) 1997-02-26
DE69636597D1 (de) 2006-11-16
US6482956B2 (en) 2002-11-19
EA000952B1 (ru) 2000-08-28
CA2228296A1 (en) 1997-02-13
EP0841925A4 (en) 2001-10-17
EP0843551A1 (en) 1998-05-27
AU717172B2 (en) 2000-03-16
MX9800975A (es) 1998-04-30
AU6764596A (en) 1997-02-26
DE69619116D1 (de) 2002-03-21
US5969151A (en) 1999-10-19
DE69619116T2 (de) 2002-09-19
ES2273350T3 (es) 2007-05-01
JPH11511133A (ja) 1999-09-28
AP9801182A0 (en) 1998-01-31
HUP9902817A2 (hu) 1999-12-28
BR9609914A (pt) 1999-07-06
HUP9902817A3 (en) 2001-03-28
US20020072614A1 (en) 2002-06-13
CN1196680A (zh) 1998-10-21
EP0841925A1 (en) 1998-05-20
BG102229A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
TR200002896T2 (tr) Kalsilitik Bileşimler
TR199801255T2 (tr) Vitronektin reseptör antagonistleri.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR199900639T2 (tr) Olanzapin dihidrat D.
ATE219064T1 (de) Piperazinderivative als tachykinin antagonisten
ES2175066T3 (es) Antagonistas triciclicos de la vasopresina.
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
ATE242243T1 (de) Zyklische verbindungen, ihre herstellung und ihre verwendung als tachykininrezeptorantagonisten
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
TR199801253T2 (tr) Vitronektin reseptörü antagonistleri.
TR200003244T2 (tr) Yeni kullanım
SE9704544D0 (sv) Novel compounds
TR200001544T2 (tr) Yeni bileşikler.
SE9702773D0 (sv) Novel compounds
ID23374A (id) Halogenopirimidin
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
TR199802284T2 (tr) Dopamin D3 reseptörlerinin modülatörleri olarak tetrahidroizokuinolin türevleri.
SE9802729D0 (sv) Novel Compounds
TR200000152T2 (tr) Yeni bileşikler.
BR9711586A (pt) Compostos e uso dos mesmo
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
TR199800152T1 (tr) Endotelin Reseptör Antagonistleri
TR200200357T2 (tr) Yeni integrin reseptör antagonistleri
NO971997D0 (no) Bruk av immunmodulerende midler
ID21353A (id) Senyawa bi-aromatik yang terikat melalui radikal heteroetilena, serta komposisi farmasi dan kosmetik yang mengandungnya